Clinical trials group Hvivo announces departure from Irish stock market
Company says its primary operations, along with the majority of its employees and investor base, are based in the UK
Hvivo
Irish Life has paid €1.73bn in dividends to overseas parent since it was bought from the State a decade ago
The best news, analysis and comment from The Irish Times business desk
Ireland’s Mr IPO and his plans to make more companies public
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Hvivo chairman Cathal Friel sells remaining shares for €7.3m
Businessman oversaw the initial flotation in 2019 of clinical trials group that became Hvivo
Hvivo revenue reaches record in fist half of 2024
Company’s Canary Wharf facility provides scope for growth
Hvivo seals €2.9m contract for Covid-19 characterisation study
Group says establishment of a Covid challenge model is a key step to penetrating a new and expanding market
Hvivo on track to hit target as it records revenue high in 2023
Company says it will begin paying annual dividends
Pharmaceutical services company Hvivo sells almost 30m placing shares
New and existing institutional investors indicated demand for shares was in excess of those available
Hvivo signs €7.3m contract to test cold virus treatment
Pharmaceutical services company is testing drug for human rhinovirus in human challenge trial
Pharma services company Hvivo delivers record revenues in first half
Company, formerly known as Open Orphan, described the first half of 2023 as ‘another period of excellent growth’
Human drug trial contracts drive 52% jump in revenue at Hvivo
Dublin- and London-listed pharma services company has seen its order book grow 11% in first half from same period in 2022
Hvivo inks €5.9m contract with Asia-Pacific biotech to test vaccine
Deal is Dublin-listed pharma company's first in the region in over 10 years
Open Orphan subsidiary signs €6m contract for respiratory study
Company expects revenues from the contract to be recognised across 2022 and 2023
Potential RSV vaccine achieves regulatory step in US
Bavarian Nordic vaccine candidate used hVivo challenge trial to gather data
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices